First, decode what kind of rejection you have
Platforms use different words for very different situations, and the fix depends on which one you got. A single-ad disapproval names a policy and leaves the account healthy: fixable at the ad or page level. A recurring disapproval across many ads pointing at the same policy usually means the cause is the account's certification status or the landing page, not the copy. An account-level restriction or suspension is the serious tier, and 'circumventing systems' is the most serious phrase in the ecosystem: it means the platform believes you tried to route around enforcement, and it rarely reverses.
Pull the exact policy name from the disapproval notice before changing anything. Guessing at fixes burns review cycles and, on repeated resubmission of the same violation, escalates accounts toward restriction.
Cause one: you're not certified for what the page sells
The most common cause by far. Google restricts promoting online prescribing, dispensing, and sale of prescription drugs, and the review looks at the destination: if the landing page sells a prescription GLP-1 program, the ad requires a certified account whatever the copy says. Meta's version is the same gate plus a written-authorization step after LegitScript certification.
The tell: disapprovals cite the healthcare, pharmaceutical, or prescription-drug policy family, and they keep coming no matter how you rewrite the ad. The fix is the certification chain itself (LegitScript, then the platform's approval), not another round of copyediting. Our LegitScript-for-Google-Ads guide covers the chain, fees, and timeline; the readiness checker on this site tells you what reviewers will find on your pages before you pay the application fee.
If rewriting the ad three times hasn't fixed it, the problem is not the ad. It's the account's certification status or the landing page.
Cause two: drug terms without the permission
Prescription drug names (semaglutide, tirzepatide, brand names) are restricted terms. Certified advertisers in the permitted countries may use them promotionally in ads, keywords, and landing pages after requesting exactly that permission in Google's application; accounts without it trip the restricted-drug-terms policy the moment a name appears, and keyword-targeting drug terms requires certification anywhere it is allowed at all.
The fix is either the permission (if you qualify: finish the chain and request drug-term usage explicitly) or genuinely condition-first assets: copy, keywords, and pages built around the program and the condition, with no drug names anywhere in the promoted path. Half-measures fail: a clean ad pointing at a page with a drug-name headline is still a drug-term promotion.
Cause three: the claim crossed a line
Three claim families get GLP-1 ads rejected even from fully certified accounts. Outcome promises and guarantees: specific pounds, specific timelines, 'guaranteed results,' and before/after framings that imply typicality. Equivalence claims for compounded medication: 'same as' or 'generic' a branded drug, which is simultaneously a platform violation and the exact language the FDA's 2025 warning-letter waves cited. And deceptive pricing: a headline price that excludes the medication or labs, the core of the FTC's NextMed order.
The fix is structural honesty, not softer adjectives: describe the program and the clinical process, state the real all-in price, frame eligibility as clinician-decided, and keep every number substantiatable. Claims discipline is also what keeps the FTC and FDA out of your inbox, which matters more than the ad slot.
Cause four: the landing page failed review
Reviewers read the destination like an inspector: business name and physical address visible, licensure and the prescription requirement disclosed, the telehealth process described accurately, full pricing, privacy policy and consent present, and the compounded-medication disclosure where it applies (not FDA approved, clinician's discretion, not all patients qualify). A page missing these fails ads review and would fail certification review for the same reasons.
The fix list is mechanical and checkable: run the readiness checker, work the pre-application checklist, and resubmit only after the page passes. Ads-plus-page consistency matters too: the ad's offer, price, and product must match what the page actually says.
Cause five: targeting used a tool you no longer have
Health advertisers lost the personalization toolkit: on Google, the health sensitive-interest rules bar remarketing lists, Customer Match, and lookalike-style expansion; on Meta, health-categorized accounts under core-setup restrictions lose lower-funnel event optimization from the pixel and Conversions API. Campaigns built on those tools fail or silently underdeliver, and audience uploads with health-implying names draw enforcement of their own.
The fix is architectural: search-intent-led acquisition on Google, lead forms and upper-funnel optimization on Meta, and first-party measurement for the truth about CAC. Our pixels-and-HIPAA guide covers the measurement side, which for health brands is as much a privacy obligation as a platform rule.
What never works (and what it costs)
The workaround family (a fresh domain for the same offer, a borrowed or agency certified account, cloaked pages that show reviewers one thing and users another, resubmitting the identical ad until a different reviewer passes it) is exactly what circumventing-systems enforcement was built for. It converts a fixable disapproval into a suspension that follows the payment methods, domains, and people involved, on every platform at once, because they share signals.
The boring sequence wins: decode the cause, apply the matching fix, finish the certification chain if that is the cause, and resubmit once, clean. Accounts that operate this way accumulate the thing that actually protects them: a history of clean review outcomes.
Where EmbedCare fits
Partner storefronts on EmbedCare are built to the disclosure standards reviewers check and ship with certification managed, which removes causes one, two, and four before the first ad runs. If you are holding a rejection notice right now, the diagnosis above is usually enough to fix it; if it is not, book a demo and bring the notice, because mapped problems are fixable ones.
Frequently asked
- Why do my GLP-1 ads keep getting rejected?
- Five causes cover nearly every case: the account is not certified for prescription drug services while the landing page sells one; a drug term appeared without the drug-terms permission; a claim crossed the outcome, equivalence, or pricing-deception lines; the landing page fails disclosure review; or the targeting used remarketing or custom-audience tools health advertisers no longer have. The disapproval's policy name tells you which.
- Why was my ad rejected when it doesn't mention any drug?
- Because review looks at the destination. If the landing page sells a prescription GLP-1 program, the ad is promoting prescription drug services and requires a certified account regardless of copy. Rewriting the ad cannot fix a certification-status cause.
- How do I fix a 'restricted drug terms' disapproval?
- Either complete the certification chain and explicitly request the permission to use prescription drug terms in ads, keywords, and landing pages, or remove drug names from the entire promoted path, page included. A clean ad pointing at a drug-name headline still trips the policy.
- Can I appeal a GLP-1 ad rejection?
- Yes, and appeals work when the cause is actually fixed first: correct the claim, page, or certification gap, then appeal or resubmit once. Resubmitting the same violation repeatedly escalates toward account restriction rather than around it.
- My account was suspended for circumventing systems. Now what?
- That is the most serious enforcement tier and it rarely reverses; it typically follows fresh domains, borrowed certified accounts, or cloaking. Take honest inventory of what triggered it before doing anything, because opening new accounts for the same operation deepens the finding. Rebuilding on a compliant, certified foundation is the only durable path.
Want pricing for your program, and the Rx menu that goes with this?
The partner overview in one email; a human follows up with pricing scoped to your program.